Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Warts × methyl 5-aminolevulinate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 4 Carcinoma, Basal Cell 3 Warts 1 Carcinoma, Squamous Cell 1 Bowen's Disease 1

Interventions

N-phenylacetoaminomethylene-DL-p-nitrophenylalanine 2 2-Propanol 2 methyl 5-aminolevulinate 1 Zinc Sulfate 1 Vaccination 1 VP-102 1 Tuberculin 1 Photochemotherapy 1 PRA1 protein, Candida albicans 1 Exercise 1 Cantharidin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00472459 2025-04-18

Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer

Galderma R&D

Phase 3 Completed

82 enrolled 20 charts

Bowen's Disease, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Warts, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡